Top Markets
Coin of the day
Zynerba Pharmaceuticals, Inc. Zynerba Pharmaceuticals, Inc.

Zynerba Pharmaceuticals, Inc.

ZYNE
株式のランク #26767
Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in... Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in the clinical development phase. Its primary objective is to create and advance medicinal transdermal cannabinoid treatments specifically for uncommon and scarcely encountered neuropsychiatric conditions. A key product in its pipeline is Zygel, a pharmaceutical-grade cannabidiol expertly crafted into a gel with enhanced skin penetration for topical application. Originally established as AllTranz, Inc., the company adopted its current name, Zynerba Pharmaceuticals, Inc., in August 2014. Founded in 2007, Zynerba Pharmaceuticals maintains its headquarters in Devon, Pennsylvania.
株価
$1.30
最終同期: 2023-10-13
時価総額
$38.02M
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Zynerba Pharmaceuticals, Inc. (ZYNE)

カテゴリー

Zynerba Pharmaceuticals, Inc.(ZYNE)の株式分割履歴
Zynerba Pharmaceuticals, Inc.株(シンボル:ZYNE)は合計で0回の株式分割を実施しました。
最新の株式分割はAug 20, 2026に行われました。
Aug 20, 2026より前に購入されたZYNE株は、現在0ZYNE株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割